These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 35911257)

  • 1. Dyshidrosiform Bullous Pemphigoid Triggered by COVID-19 Vaccination.
    Shanshal M
    Cureus; 2022 Jun; 14(6):e26383. PubMed ID: 35911257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dyshidrosiform Bullous Pemphigoid: Case Reports and Review.
    Cohen PR
    Cureus; 2020 Jan; 12(1):e6630. PubMed ID: 32064205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dyshidrosiform Bullous Pemphigoid.
    Cohen PR
    Medicina (Kaunas); 2021 Apr; 57(4):. PubMed ID: 33924249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bullous pemphigoid after second dose of mRNA- (Pfizer-BioNTech) Covid-19 vaccine: A case report.
    Alshammari F; Abuzied Y; Korairi A; Alajlan M; Alzomia M; AlSheef M
    Ann Med Surg (Lond); 2022 Mar; 75():103420. PubMed ID: 35251600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dyshidrosiform pemphigoid with Parkinsonism in a nonagenarian Maharashtrian female.
    Behlim T; Sharma YK; Chaudhari ND; Dash K
    Indian Dermatol Online J; 2014 Oct; 5(4):482-4. PubMed ID: 25396135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A subepidermal blistering disease with histopathological features of dermatitis herpetiformis and immunofluorescence characteristics of bullous pemphigoid: a novel subepidermal blistering disease or a variant of bullous pemphigoid?
    Salmhofer W; Kawahara Y; Soyer HP; Kerl H; Nishikawa T; Hashimoto T
    Br J Dermatol; 1997 Oct; 137(4):599-604. PubMed ID: 9390339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Patient Develops Bullous Rash After Receiving the Second Dose of COVID-19 Vaccine.
    Nida SS; Tobon GJ; Wilson M; Chauhan K
    Cureus; 2022 Sep; 14(9):e29786. PubMed ID: 36340561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bilateral localized bullous pemphigoid in a young adult patient: A case report.
    Nourmohammadpour P; Akhdar M; Ghanadan A; Peymanfar AA; Saberi F; Keshavarz-Fathi M
    SAGE Open Med Case Rep; 2023; 11():2050313X231190730. PubMed ID: 37533489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New-Onset Bullous Pemphigoid in a COVID-19 Patient.
    Olson N; Eckhardt D; Delano A
    Case Rep Dermatol Med; 2021; 2021():5575111. PubMed ID: 34211788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dyshidrosiform pemphigoid localized on the hands in a child: a rare occurrence.
    Dayal S; Sahu P; Jain VK
    An Bras Dermatol; 2017; 92(5):714-716. PubMed ID: 29166515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermolysis bullosa acquisita and anti-p200 pemphigoid as major subepidermal autoimmune bullous diseases diagnosed by floor binding on indirect immunofluorescence microscopy using human salt-split skin.
    Goyal N; Rao R; Shenoi SD; Pai S; Kumar P; Bhogal BS; Schmidt E; Zillikens D
    Indian J Dermatol Venereol Leprol; 2017; 83(5):550-555. PubMed ID: 28749386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Initial manifestation of bullous pemphigoid simulating dyshidrosis palmoplantaris].
    Radloff P; Vieluf D; Mensing H; Ring J
    Hautarzt; 1994 Feb; 45(2):97-9. PubMed ID: 8150639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dyshidrosiform bullous pemphigoid].
    Mohr C; Duschet P; Bonsmann G; Luger TA; Gschnait F; Schwarz T
    Hautarzt; 1993 Dec; 44(12):785-8. PubMed ID: 8113043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New-onset or flare-up of bullous pemphigoid associated with COVID-19 vaccines: a systematic review of case report and case series studies.
    Ghanaatpisheh A; Safari M; Haghshenas H; Motamed-Sanaye A; Atefi AH; Kamangarpour K; Bagherzadeh MA; Kamran-Jahromi A; Darayesh M; Kouhro N; Bahadori AR; Esfandiari MA
    Front Med (Lausanne); 2024; 11():1293920. PubMed ID: 38654835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laboratory Diagnosis and Clinical Profile of Anti-p200 Pemphigoid.
    Meijer JM; Diercks GF; Schmidt E; Pas HH; Jonkman MF
    JAMA Dermatol; 2016 Aug; 152(8):897-904. PubMed ID: 27167149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between COVID-19 vaccination and bullous pemphigoid - a case series and literature review.
    Wan V; Chen D; Shiau CJ; Jung GW
    SAGE Open Med Case Rep; 2022; 10():2050313X221131868. PubMed ID: 36274858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemorrhagic vesiculobullous eruption on the palms and the soles as presentation of dyshidrosiform bullous pemphigoid.
    Michelerio A; Croci GA; Vassallo C; Brazzelli V
    JAAD Case Rep; 2018 Jan; 4(1):61-63. PubMed ID: 29387751
    [No Abstract]   [Full Text] [Related]  

  • 18. [A case of dyshidrosiform pemphigoid].
    Yamada Y; Sugita K; Izu K; Nakamura M; Hashimoto T; Tokura Y
    J UOEH; 2011 Jun; 33(2):183-7. PubMed ID: 21702123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential occurrence of primary cutaneous indeterminate cell histiocytosis after oesophageal cancer and subsequent bullous pemphigoid: a case report.
    Jia X; Shen L; Zhu L; Liu D
    Br J Hosp Med (Lond); 2024 Jul; 85(7):1-7. PubMed ID: 39078907
    [No Abstract]   [Full Text] [Related]  

  • 20. Childhood bullous pemphigoid treated by i.v. immunoglobulin.
    Xiao T; Li B; Wang YK; He CD; Chen HD
    J Dermatol; 2007 Sep; 34(9):650-3. PubMed ID: 17727369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.